Briefly, each course consisted of DRN at a dose of 45 mg/m2 given daily on days 1, 2, and 3 and a total dose of 2 g/m2 of ara-C as a 72-hour continuous infusion (CI) beginning on day I and again on day 10 (Ac,-D-Ac).
Entrants in protocol 8410 received DRN at a dose of 45 mg/m2 given daily on days 1, 2, and 3 and a total dose of 2 g/m2 of ara-C given as a 72-hour CI beginning on day 1, as in study 8004. However, on days 8, 9, and 10 of this first course, instead of ara-C, a daily bolus of Amsa at a dose of 200 mg/m2 was given (Ac2-D-Amsa).
Response 
